Physician profile
Andrew DO
NPI 1558847723
$961.96
in general payments reported to CMS, 2019-2025
12 companies · $660 in 2025
The $660 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $157 · 2021: $19.54 · 2024: $125 · 2025: $660.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $785.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $210.44 | 2025 | Tryptyr, Eysuvis |
| Bausch & Lomb Americas INC. | $201.62 | 2024-2025 | Infuse, Scoutpro Osmolarity System, Envista Envy Iol |
| Sun Pharmaceutical Industries INC. | $160.02 | 2025 | |
| Dompe US, INC. | $143.59 | 2025 | Oxervate |
| Shire North American Group INC | $106.68 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $33.38 | 2025 | Xdemvy |
| Biotissue Holdings INC. | $22.44 | 2025 | |
| Novartis Pharmaceuticals Corporation | $21.36 | 2019 | |
| Allergan, INC. | $19.54 | 2021 | |
| Spark Therapeutics, INC. | $17.18 | 2019 | |
| Rxsight INC | $13.52 | 2025 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Johnson & Johnson Vision Care, INC. | $12.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew DO listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.